Black FridayUp to 80% OFF
Novartis AG Sponsored ADRNovartis AG Sponsored ADRNovartis AG Sponsored ADR

Novartis AG Sponsored ADR

No trades
See on Supercharts
OverviewFinancialsNewsIdeasMindsTechnicalsForecastsSeasonalsOptionsBondsETFs

Chart


Full chart

Key facts today


Novartis raised its 2025-2030 sales outlook to 5-6% growth, boosted by confidence in key drugs. Peak sales for Kisqali increased to $10 billion and Scemblix to $4 billion.
Analyze the impactAnalyze the impact

Upcoming earnings


Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—

Key stats


Market capitalization
‪241.47 B‬ USD
Dividend yield (indicated)
2.72%
Price to earnings Ratio (TTM)
17.36
Basic EPS (TTM)
7.38 USD
Net income (FY)
‪11.93 B‬ USD
Revenue (FY)
‪50.29 B‬ USD
Shares float
‪1.90 B‬
Beta (1Y)
0.30

About Novartis AG


Sector
Health Technology
Industry
Pharmaceuticals: Major
CEO
Vasant Narasimhan
Website
novartis.com
Headquarters
Basel
Founded
1996
ISIN
US66987V1098
FIGI
BBG000LYF3S8
Novartis AG is a holding company, which engages in the business of developing, manufacturing, and marketing healthcare products. It operates through the following segments: Innovative Medicines, Sandoz, and Corporate. The Innovative Medicines segment includes researching, distributing and selling patented pharmaceuticals. The Sandoz segment focuses on marketing finished dosage form medicines and intermediary products including active pharmaceutical ingredients. The Corporate segment is involved in group management and central services. The company was founded on February 29, 1996 and is headquartered in Basel, Switzerland.

Check out other big names from the same industry as NVS.

Financials


Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—

News



Ideas



See all ideas 

Technicals


Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Analyst rating


An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Seasonals


Displays a symbol's price movements over previous years to identify recurring trends.

Highest yielding bonds


NVS6224266
Novartis Capital Corp. 5.3% 05-NOV-2055
Yield to maturity
5.41%
Maturity date
Nov 5, 2055
NVS5894401
Novartis Capital Corp. 4.7% 18-SEP-2054
Yield to maturity
5.39%
Maturity date
Sep 18, 2054
US66989HAS7
Novartis Capital Corp. 2.75% 14-AUG-2050
Yield to maturity
5.35%
Maturity date
Aug 14, 2050
US66989HAH1
Novartis Capital Corp. 4.4% 06-MAY-2044
Yield to maturity
5.31%
Maturity date
May 6, 2044
XPND
Novartis Capital Corp. 4.0% 20-NOV-2045
Yield to maturity
5.30%
Maturity date
Nov 20, 2045
NVS6224265
Novartis Capital Corp. 5.2% 05-NOV-2045
Yield to maturity
5.30%
Maturity date
Nov 5, 2045
NVS3904288
Novartis Capital Corp. 3.7% 21-SEP-2042
Yield to maturity
5.20%
Maturity date
Sep 21, 2042
NVS6224264
Novartis Capital Corp. 4.6% 05-NOV-2035
Yield to maturity
4.66%
Maturity date
Nov 5, 2035
NVS5894400
Novartis Capital Corp. 4.2% 18-SEP-2034
Yield to maturity
4.49%
Maturity date
Sep 18, 2034
NVS6224263
Novartis Capital Corp. 4.3% 05-NOV-2032
Yield to maturity
4.30%
Maturity date
Nov 5, 2032
NVS5894399
Novartis Capital Corp. 4.0% 18-SEP-2031
Yield to maturity
4.04%
Maturity date
Sep 18, 2031

See all NVS bonds 

ETFs


DFIV
Dimensional International Value ETF
Weight
0.78%
Market value
‪110.54 M‬
USD
PPH
VanEck Pharmaceutical ETF
Weight
8.66%
Market value
‪98.45 M‬
USD
DFIC
Dimensional International Core Equity 2 ETF
Weight
0.80%
Market value
‪87.45 M‬
USD
DFAI
Dimensional International Core Equity Market ETF
Weight
0.69%
Market value
‪81.30 M‬
USD
DIHP
Dimensional International High Profitability ETF
Weight
1.49%
Market value
‪70.68 M‬
USD
AVDE
Avantis International Equity ETF
Weight
0.66%
Market value
‪67.56 M‬
USD
DFAX
Dimensional World ex U.S. Core Equity 2 ETF
Weight
0.68%
Market value
‪64.60 M‬
USD
HHL
Harvest Healthcare Leaders Income ETF
Weight
5.07%
Market value
‪62.39 M‬
USD
HHL.U
Harvest Healthcare Leaders Income ETF
Weight
5.07%
Market value
‪62.39 M‬
USD
HHL.B
Harvest Healthcare Leaders Income ETF Trust Units B Unhedged
Weight
5.07%
Market value
‪62.39 M‬
USD
FVD
First Trust Value Line Dividend Index Fund
Weight
0.41%
Market value
‪34.31 M‬
USD

Explore more ETFs 

Sparks


Curated watchlists where NVS is featured.

See all sparks